This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund. Articles in this topic offer timely ...
Botox and the GLP-1 drug Trulicity are among the latest group of prescription drugs subject to price controls by Medicare. The Centers for Medicare & Medicaid Services (CMS), the federal agency that ...
WASHINGTON, D.C. — Federal health officials announced that manufacturers of 15 high-cost prescription drugs have agreed to participate in the next round of Medicare drug price negotiations, a program ...
The new cycle of Medicare drug price negotiations includes 15 high-cost drugs, with some covered under Medicare Part B for the first time. The negotiations, part of the Inflation Reduction Act, aim to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results